Chimeric Investigations into the Diamide Binding Site on the Lepidopteran Ryanodine Receptor by Christopher, George
 International Journal of 
Molecular Sciences
Article
Chimeric Investigations into the Diamide Binding Site on the
Lepidopteran Ryanodine Receptor
Ewan Richardson 1, Bartek J. Troczka 1,2, Oliver Gutbrod 3, Ulrich Ebbinghaus-Kintscher 3, Martin S. Williamson 1,
Christopher H. George 4 , Ralf Nauen 3 and Thomas G. Emyr Davies 1,*


Citation: Richardson, E.; Troczka,
B.J.; Gutbrod, O.;
Ebbinghaus-Kintscher, U.;
Williamson, M.S.; George, C.H.;
Nauen, R.; Davies, T.G.E. Chimeric
Investigations into the Diamide
Binding Site on the Lepidopteran
Ryanodine Receptor. Int. J. Mol. Sci.
2021, 22, 13033. https://doi.org/
10.3390/ijms222313033
Academic Editor: Jesus Vicente De
Julián Ortiz
Received: 11 November 2021
Accepted: 29 November 2021
Published: 2 December 2021
Publisher’s Note: MDPI stays neutral
with regard to jurisdictional claims in
published maps and institutional affil-
iations.
Copyright: © 2021 by the authors.
Licensee MDPI, Basel, Switzerland.
This article is an open access article
distributed under the terms and
conditions of the Creative Commons
Attribution (CC BY) license (https://
creativecommons.org/licenses/by/
4.0/).
1 Department of Biointeractions and Crop Protection, Rothamsted Research, Harpenden AL5 2JQ, UK;
eprichardson1@gmail.com (E.R.); B.Troczka@exeter.ac.uk (B.J.T.);
martin.williamson@rothamsted.ac.uk (M.S.W.)
2 Department of Biosciences, College of Life and Environmental Sciences, Penryn Campus, University of Exeter,
Penryn TR10 9FW, UK
3 Bayer AG, Crop Science Division, R&D, D-40789 Monheim, Germany; oliver.gutbrod@bayer.com (O.G.);
ulrich.ebbinghaus-kintscher@bayer.com (U.E.-K.); ralf.nauen@bayer.com (R.N.)
4 Institute of Life Sciences, Swansea University Medical School, Swansea SA2 8PP, UK;
christopher.george@swansea.ac.uk
* Correspondence: emyr.davies@rothamsted.ac.uk
Abstract: Alterations to amino acid residues G4946 and I4790, associated with resistance to diamide
insecticides, suggests a location of diamide interaction within the pVSD voltage sensor-like domain
of the insect ryanodine receptor (RyR). To further delineate the interaction site(s), targeted alterations
were made within the same pVSD region on the diamondback moth (Plutella xylostella) RyR channel.
The editing of five amino acid positions to match those found in the diamide insensitive skeletal
RyR1 of humans (hRyR1) in order to generate a human–Plutella chimeric construct showed that
these alterations strongly reduce diamide efficacy when introduced in combination but cause only
minor reductions when introduced individually. It is concluded that the sites of diamide interaction
on insect RyRs lie proximal to the voltage sensor-like domain of the RyR and that the main site of
interaction is at residues K4700, Y4701, I4790 and S4919 in the S1 to S4 transmembrane domains.
Keywords: diamide insecticides; chlorantraniliprole; flubendiamide; lepidoptera; Plutella xylostella;
binding site
1. Introduction
Diamides are a relatively new class of synthetic insecticidal compounds which act
on the nerve–muscle boundary, causing contraction and paralysis of insect muscle cells.
Members of the class vary in their spectrum of control, but the majority of these insecticides
display extremely clean toxicological profiles. Diamide insecticides target the insect’s
ryanodine receptor (RyR) and are highly effective against a variety of insect pests (es-
pecially those in the order Lepidoptera) but have little effect against mammalian RyRs.
Characterisation of the concentration–response relationship in various mammalian (mouse
C2C12, rat PC12) cell lines expressing RyRs and recombinant cells expressing insect RyRs
indicated chlorantraniliprole (CLR) to be some 300-fold less potent against mouse skeletal
muscle RyR (RyR1) and >2000-fold less potent against rat cardiac muscle RyR2 compared to
lepidopteran and dipteran RyR-expressing cells [1]. Similarly, flubendiamide (FLB) exhibits
>500-fold differential selectivity toward insect over mammalian (rat PC12) receptors [2].
Differences in diamide efficacy between mammals and insects are suspected to be
attributable to differences in the structure of the diamide binding site on the RyR. The
approximate diamide binding region on the RyR has been elucidated progressively over the
past decade, primarily as a by-product of investigations into incidences of field-resistance
to diamide insecticides, uncovering a selection of closely located, causatively linked,
point mutations on the RyR of lepidopteran pests, centred around residues G4946 and
Int. J. Mol. Sci. 2021, 22, 13033. https://doi.org/10.3390/ijms222313033 https://www.mdpi.com/journal/ijms
Int. J. Mol. Sci. 2021, 22, 13033 2 of 13
I4790 (Plutella xylostella numbering) (reviewed in [3]). Additionally, an earlier study by
Tao et al. [4] bears further detailed discussion, as it has been instrumental in pinpointing the
diamide binding region. By creating a chimeric RyR channel, composed of the Drosophila
melanogaster (fruit fly) and Meloidogyne incognita (root knot nematode) RyR sequence, a
region within the C-terminus of the receptor was found to be critically involved in the
formation of the diamide binding site, in line with the findings of a previous study [5]. A
defining shorter chimeric segment within this C-terminal region, consisting of a 45aa region
of the nematode sequence, located proximal to transmembrane segment S1 (corresponding
to P. xylostella aa numbering 4659–4703), produced a channel that was insensitive to CLR
(up to 30 µM). Of the 45 amino acids replaced, most are unlikely candidates to be involved
in diamide interaction. The first 30 aa lie in a zone of high sequence divergence, even within
insects, hence the conservation of a diamide binding site here would seem improbable.
The last 10 amino acids (aa 4694–4703), by contrast, are highly conserved, likely due to
being at the start of the S1 membrane-spanning domain. Six of these amino acids are
identical between humans and insects, leaving just K4695N, K4700R, Y4701F and V4702L
(P. xylostella numbering) as possible loci of this major difference between species in diamide
binding efficacy. The latest episodes of diamide resistance reported in the rice stem borer
(Chilo suppressalis) add further support to the Tao et al. study [4], with alleles 4701C and
4701D found (alone) in the resistant population [6]. The importance of these positions was
recently also highlighted by Ma et al. [7] in an analysis of a high-resolution cryo-electron
microscopy (cryo-EM) structure of rabbit RyR1 in complex with CLR.
To further delineate the diamide interaction site(s) on the lepidopteran RyR channel,
targeted alterations were made to five amino acid positions (including K4700 and Y4701)
located within transmembrane-spanning regions S1 to S4 of the voltage sensor-like domain
on the P. xylostella RyR to match those found in the skeletal RyR1 of humans (hRyR1),
generating a human–Plutella chimeric construct. This modified RyR construct was then ex-
pressed in vitro and challenged with diamide insecticides to assess the degree of sensitivity
of the channel to the insecticides.
2. Results
In the current study, candidate diamide interacting residues on the insect RyR channel
identified in previous studies were further scrutinized and assessed through alignment
of 44 arthropod, nematode and vertebrate RyR amino acid sequences. Highly conserved
but distinct insect vs. mammalian residues K4700R and Y4701F (located on TMS1), I4790C
(TMS2), S4919L (TMS3) and V4945M (TMS4) (Figure 1a), were considered suitable candi-
dates for further study. The justifications for their selection are summarized in Table 1.
Notably, almost all the diamide resistance-associated mutations discovered to date
(e.g., G4946E/V, I4790M/K, Y4701C/D) are concentrated within a 250 aa region close to
the C-terminus of the protein, which in the 3D structure is located within the TM S1–S4
domain, peripheral to the channel pore (Figure 1b,c). This 250 aa region, which is similar
in structure to the voltage sensor domain (VSD) of voltage-gated channels such as the
bacterial KcsA potassium channel, is referred to here as the ‘diamide resistance region’. The
candidate amino acid substitutions identified above for further binding site studies, when
plotted onto the 3D structure, can be seen to form a ring-like distribution across the crown
of this VSD (Figure 1c).
2.1. RFCLM: A Chimeric RyR Channel Combining Moth with Mammal
The methodology chosen to investigate the binding region closely follows that of
Tao et al. [4], whereby Spodoptera frugiperda Sf9 cells are transiently transfected with
moth/human RyR chimeras in order to iteratively refine the residues and locus most
responsible for diamide insensitivity in the mammalian channel. To this end, four PxRyR
recombinant constructs were expressed in Sf9 cells and evaluated in terms of diamide effect
relative to WT.




Figure 1. The ‘diamide resistance region’ in lepidopteran RyR. (a) Alignment of Plutella xylostella 
PxRyR (P.x) and human skeletal muscle hRyR1 (H.s) amino acid sequences. TM regions S1–S4 (de-
lineated with yellow bars), divergent region (grey), aa residues investigated in this paper (blue), 
further residues that may be of additional interest based on the amino acid alignments (pink). (b) 
PxRyR-rRyR1 homology model of the RyR transmembrane region showing two isomers in dimeric 
formation, with the pore region shown in blue (PF, Pore Forming; CTD, C-terminal Domain; 
pVSD, Voltage Sensor Domain) and TM regions S1–S4 shown in yellow (boxed and highlighted). 
(c) PxRyR-rRyR1 homology model of the pVSD (labeled as in (a)), displaying a ring of amino acids 
implicated in diamide binding (blue) and further residues that may be of additional interest based 
on the amino acid alignments (pink) but which were not included in the current study. The PxRyR-
rRyR1 homology model was generated using Pymol and Schrodinger software. 
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PxRyR (P.x) and hum n skeletal muscle hRyR1 (H.s) amino ac d sequences. TM regions S1–S4
(delineated with yellow bars), divergent region (grey), aa residues investigated in this paper (blue),
further residues that may be of additional interest based on the amino acid alignments (pink).
(b) PxRyR-rRyR1 hom logy model of the RyR tra smembrane region showing two isomers in
dimeric formation, with the pore region shown in blue (PF, Pore Forming; CTD, C-terminal Domain;
VSD, Voltage Se sor Dom in) and TM regions S1–S4 shown in yellow (boxed and highlighted).
(c) PxRyR-rRyR1 homology model of the pVSD (labeled as in (a)), displaying a ring of amino acids
implicated in diamide binding (blue) and further residues that may be of additional interest based on
the amino acid alignments (pink) but which were not included in the current study. The PxRyR-rRyR1
homology model was generated using Pymol and Schrodinger software.
Table 1. PxRyR amino acid positions altered to resemble hRyR1. The actual residue at each position is noted for susceptible




Insect or Arthropod Species Residue in Resistant Species
Additional Justification for
Selection of Residue
4945 Valine (V) Methionine (M) in vertebratesLeucine (L) in nematodes Sequentially adjacent to G4946E [8,9]
4919 Serine (S) or asparagine (N) Leucine (L) in vertebratesArginine (R) in nematodes
4790 Isoleucine (I) Leucine (L) in vertebratesCysteine (C) in nematodes
Methionine (M) at this position shown to
confer diamide resistance [10]
4701 Tyrosine (Y)
Phenylalanine (F) or
methionine (M) in vertebrates
Lysine (K) in nematodes
Terminal residue of the Tao chimera [4]
4700 Lysine (K) Arginine (R) in vertebratesGlutamate (E) in nematodes Penultimate residue of the Tao chimera [4]
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In the first instance, a chimeric construct composed of the wild-type P. xylostella
(WT-PxRyR) incorporating five amino acid alterations was created, edited to match those
residues present in human or rabbit (Oryctolagus cuniculus) RyR1. The chimeric construct
is hereby referred to as RFCLM-PxRyR, reflecting the five alterations: K4700R; Y4701F;
I4790C; S4919L; V4945M (Figure 2).
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2.2. Characterisation of RFCLM Caffeine Response
Concentration-dependent caffeine-stimulated Ca2+ release was measured in Sf9 cells
expressing homotetrameric RFCLM-PxRyR (Figure 3a). No substantial difference in signal
amplitude between the WT and RFCLM expressed constructs in response to caffeine was
indicated within the tested range (Figure 3b).




Figure 3. Response of RFCLM-PxRyR to increasing concentrations of caffeine. (a) Averaged re-
sponse of cells in a given field of view. Data is presented as mean (solid line) and standard error of 
the mean (SEM). (b) Proportional normalised responses (see Methods) of those same RFCLM-ex-
pressing cells (orange) compared alongside WT-expressing cells (grey). Error bars are standard error 
of mean (SEM). 
2.3. Characterisation of RFCLM Diamide-Response 
Concentration-response experiments were conducted for RFCLM-PxRyR against 
CLR and FLB. Poor solubility limited the maximum applied concentration for both dia-
mides to 50 µM. A WT-PxRyR EC50 of 0.015 µM for CLR and 0.27 µM for FLB are compa-
rable to those generated by previous authors [8] (EC50s = 0.017 µM for CLR; 0.25 µM for 
FLB). RFCLM-PxRyR demonstrated a decreased sensitivity to CLR compared to the WT-
PxRyR construct and near elimination of FLB-responsiveness (Figure 4a). An approximate 
minimum ‘sensitivity ratio’ (SR) for CLR was ascertained by comparison of WT-PxRyR 
EC50 (0.015 µM) with the ‘minimum EC50’ of RFCLM-PxRyR (20.4 µM), giving a SR = 1,360-
fold. In the case of FLB (sulfoxide form), the responses were small and transient up to and 
beyond the limit of solubility of the compound (Figure 4a). RFCLM-PxRyR expressing 
cells did at no point display a typical, irreversible activation response to FLB. The closest 
approximation to an SR, made by comparing the EC10 for WT (50nM) with that for RFCLM 
(50 µM), gives an approximate SR of 1,000-fold for FLB. 
The impact of these five amino acid changes upon diamide efficacy is shown to be 
extreme where diamide interaction is all but abolished, creating a channel similar in dia-
mide interaction properties to the human hRyR channel itself (RFCLM EC50 for CLR = 
20.4 µM, which is comparable to studies in mice [1]). The results confirm the location of the 
diamide interaction site as being within the voltage sensor-like domain. Figure 4b indi-
cates the relative positions of the five modified residues in the pVSD region, where they 
Fig r 3. Respo se of RFCLM-PxRyR to increasing concentrations of caffeine. (a) Averaged response
of cells in a given field of view. Data is presented as mean (solid line) and standard error of the
mean (SEM). (b) Proportional normalised responses (see Methods) of those same RFCLM-expressing
cells (orange) compared alongside WT-expressing cells (grey). Error bars are standard error of
mean (SEM).
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2.3. Characterisation of RFCLM Diamide-Response
Concentration-response experiments were conducted for RFCLM-PxRyR against CLR
and FLB. Poor solubility limited the maximum applied concentration for both diamides
to 50 µM. A WT-PxRyR EC50 of 0.015 µM for CLR and 0.27 µM for FLB are comparable
to those generated by previous authors [8] (EC50s = 0.017 µM for CLR; 0.25 µM for FLB).
RFCLM-PxRyR demonstrated a decreased sensitivity to CLR compared to the WT-PxRyR
construct and near elimination of FLB-responsiveness (Figure 4a). An approximate mini-
mum ‘sensitivity ratio’ (SR) for CLR was ascertained by comparison of WT-PxRyR EC50
(0.015 µM) with the ‘minimum EC50’ of RFCLM-PxRyR (20.4 µM), giving a SR = 1360-fold.
In the case of FLB (sulfoxide form), the responses were small and transient up to and
beyond the limit of solubility of the compound (Figure 4a). RFCLM-PxRyR expressing
cells did at no point display a typical, irreversible activation response to FLB. The closest
approximation to an SR, made by comparing the EC10 for WT (50nM) with that for RFCLM
(50 µM), gives an approximate SR of 1000-fold for FLB.
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Figure 4. (a) RFCLM-PxRyR is only activated by CLR at very high concentrations (>10 µM) but
is not activated by FLB at its limit of solubility. Graphs display the dose–response relationship of
RFCLM-PxRyR (red fill) to CLR and FLB (with WT PxRyR (grey fill) response for comparison). CLR-
and FLB-induced Ca2+ release was normalised to the maximal caffeine-evoked Ca2+ release in the
same cells to calculate the proportional normalised response (PNR), which is presented here as
% maximum PNR. (b) Px -rRyR1 homol gy model of the RFCLM-PxRyR pVSD, displayed in
( ) longitudinal and (ii) transverse or e tati n. Po itions of th five amino acid ubstitutions are
marked; dotted lines indicate that the residue is hidden within the str cture. The h mology model
was generated using Pymol and Schrodinger software.
The impact of these five amino acid changes upon diamide efficacy is shown to
be extreme where diamide interaction is all but abolished, creating a channel similar
in diamide interaction properties to the human hRyR channel itself (RFCLM EC50 for
CLR = 20.4 µM, which is comparable to studies in mice [1]). The results confirm the location
of the diamide interaction site as being within the voltage sensor-like domain. Figure 4b
indicates the relative positions of the five modified residues in the pVSD region, where
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they encircle a cavity of high electronegativity. Such a region of high electronegativity,
surrounded by an opening of neutral and electropositive residues, is a common feature of
voltage-gated ion channels, frequently representing the site of ligand interaction.
2.4. Unpicking the RFCLM Modification
In pursuit of identifying which of the five amino acid residues in WT-PxRyR con-
tributes most significantly to the lepidopteran RyR susceptibility to diamides, three of the
five RFCLM amino acid substitutions were substituted individually, or in pairs, into the
WT-PxRyR construct, and their sensitivity to CLR assessed.
Of the five altered aa residues, a K4700R-Y4701F (RF-PxRyR) combination was consid-
ered a strong candidate to be mediating the observed effects, based on the previous work by
Tao et al. [4]. RF-PxRyR, when expressed in Sf9 cells, shows a highly significant reduction
in CLR response relative to WT-PxRyR (Figure 5) and suggests that the two amino acid
alterations K4700R and Y4701F in tandem are responsible for mediating a majority of the
RFCLM-PxRyR phenotype.




Figure 5. RF-PxRyR and RFCLM-PxRyR share a similar phenotypic response to CLR exposure. Sf9 cells (n = 10) expressing 
either Wild-Type (grey), RF (blue/purple) or RFCLM (yellow/orange) PxRyR were exposed to 2 µM and 20 µM concentra-
tions of CLR. All diamide responses are expressed as proportional normalised responses (PNRs). Error bars represent 
SEM. 
When K4700R, Y4701F and I4790C substitutions were substituted individually into 
the WT-PxRyR background, all three novel variants were found to confer a significant 
reduction in diamide response amplitude at the four discriminating doses of CLR tested 
(Table 2, Figure 6). However, the response magnitude of each individual change was 50–
100 times lower than the synergistic effect of all five changes combined (RFCLM-PxRyR). 
The minimum concentration at which any of the modified PxRyR’s registered a response 
was 0.04 µM, a dose that exceeds the EC50 of the WT-PxRyR (0.015 µM CLR). Y4701F and 
I4790C do not respond at this concentration and their response is not significantly different 
from that of RFCLM-PxRyR. The magnitude of the K4700R response at 0.04 µM is 10–20% 
compared to the WT response, whereas the introduction of either Y4701F or I4790C is as-
sociated with a much more robust and significant reduction in CLR efficacy. It is notable 
that despite K4700R and Y4701F individually giving just a moderate (up to 26-fold) re-
duction in diamide efficacy, when the two substitutions are combined the resulting RF-
PxRyR displays the same diamide-resistant phenotype as RFCLM-PxRyR (RR >1,000-fold). 
  
Figure 5. RF-Px yR and RFCLM-PxRyR share a similar phenotypic response to CLR exposure. Sf9
cells (n = 10) expressing either Wild-Type (grey), RF (blue/purple) or RFCLM (yellow/orange) PxRyR
were exposed to 2 µM and 20 µM concentrations of CLR. All diamide responses are expressed as
proportional normalised responses (PNRs). Error bars represent SEM.
When K4700R, Y4701F and I4790C substitutions were substituted individually into
the WT-PxRyR background, all three novel variants were found to confer a significant
reduction in diamide response amplitude at the four discriminating doses of CLR tested
(Table 2, Figure 6). However, the response magnitude of each individual change was
50–100 times lower than the synergistic effect of all five changes combined (RFCLM-PxRyR).
The minimum concentration at which any of the modified PxRyR’s registered a response
was 0.04 µM, a dose that excee s the EC50 of the WT-PxRyR (0.015 µM CLR). Y4701F
and I4790C do not respond at this concentration a d their response is not significantly
different from that of RFCLM-PxRyR. The magnitude of the K4700R response at 0.04 µM
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is 10–20% compared to the WT response, whereas the introduction of either Y4701F or
I4790C is associated with a much more robust and significant reduction in CLR efficacy.
It is notable that despite K4700R and Y4701F individually giving just a moderate (up
to 26-fold) reduction in diamide efficacy, when the two substitutions are combined the
resulting RF-PxRyR displays the same diamide-resistant phenotype as RFCLM-PxRyR
(RR > 1000-fold).
Table 2. Comparison of the responses of PxRyR sequence variants to discriminating CLR concentrations (a–d). Grey boxes
list the average response of that construct (PNR). White boxes display indices of significance, based on LSD comparisons of
amplitude between the variants. N.S. = Not Significant; * = p < 0.05; *** = p < 0.001. The least significant difference (LSD)
consists of a pairwise comparison of mean average response amplitude between the constructs compared to the standard
deviation of all groups combined.
(a) 0.04 µM CLR (b) 0.1 µM CLR
WT K4700R Y4701F I4790C RFCLM WT K4700R Y4701F I4790C RFCLM
WT 1 *** *** *** *** WT 1 *** *** *** ***
K4700R 0.2 *** *** *** K4700R 0.51 * *** ***
Y4701F 0.039 N.S. N.S. Y4701F 0.33 * ***
I4790C 0.021 N.S. I4790C 0.18 *
RFCLM 0.0061 RFCLM 0.0038
(c) 0.4 µM CLR (d) 1 µM CLR
WT K4700R Y4701F I4790C RFCLM WT K4700R Y4701F I4790C RFCLM
WT 1 * *** *** *** WT 0.99 N.S. N.S. N.S. ***
K4700R 0.69 * N.S. *** K4700R 0.96 N.S. N.S. ***
Y4701F 0.43 N.S. *** Y4701F 1.039 N.S. ***
I4790C 0.55 *** I4790C 0.89 ***
RFCLM 0.025 RFCLM 0.042
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2.5. Assessing the Contribution of Y4701F on Flubendiamide Efficacy 
Y4701 alterations (Y4701C/D) have been found in diamide-resistant populations of 
C. suppressalis and are apparently increasing in frequency [6]. Bioassays of these popula-
tions indicate that changes at this residue are involved in a 250-fold resistance to CLR. 
This amino acid change was therefore hypothesised to play a central role in the RF phe-
notype (Figure 5). 
It has been established in this study that this residue appears to play a more sig-
nificant role in CLR insensitivity than its neighbour, K4700 (Figure 6). However, field 
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2.5. Assessing the Contribution of Y4701F on Flubendiamide Efficacy
Y4701 alterations (Y4701C/D) have been found in diamide-resistant populations of
C. suppressalis and are apparently increasing in frequency [6]. Bioassays of these popula-
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tions indicate that changes at this residue are involved in a 250-fold resistance to CLR. This
amino acid change was therefore hypothesised to play a central role in the RF phenotype
(Figure 5).
It has been established in this study that this residue appears to play a more significant
role in CLR insensitivity than its neighbour, K4700 (Figure 6). However, field studies have
indicated that substitutions at Y4701 might have differential effects vs. CLR and FLB [11].
Accordingly, the impact of the residue upon FLB efficacy was tested. As displayed in
Figure 7, the Y4701F substitution surprisingly does not confer decreased sensitivity to FLB.
Indeed, the alteration may confer an increase in FLB susceptibility by up to 5-fold.
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3. Discussion
This study builds upon the methodological approach of Tao et al. [4], using a targeted
amino acid substitution approach to generate a (Plutella–human) RyR chimera to extend
knowledge of the diamide binding region on the insect RyR. Using this approach, we iden-
tified five amino acid substitutions within human RyR1, referred to as RFCLM (K4700R;
Y4701F; I4790C; S4919L; V4945M (P. xylostella numbering)), which have a profound im-
pact upon diamide efficacy when introduced in concert into an otherwise WT-PxRyR
background. These five alterations when mapped on to a 3D homology model of the
RyR protein were shown to be located in close proximity to one another, as well as to
well-characterised diamide resistance-associated mutations, and all lie within the previ-
ously defined ‘diamide-resistance region’ on the voltage senor-like (pVSD) domain in the
transmembrane region of the channel. Further investigations indicated that two of the
five residues, K4700R and Y4701F, were together responsible for a reduction in diamide
sensitivity of approximately equal magnitude to t at generated by the five residues RF-
CLM in concert. It seems cle r from these results that the relatively moderate phenotypes
associated with each individual change combine additively, o synergistically, to provide a
high level of insensitivity to diamide insecticides.
Fi ld-deriv d, resistance-causing mut tions, such as G4946E/V [9,12], I4790M/K [10,13],
Y4701C/D [6] and Y4922F [11], seem ost l kely to mediate their effects through topo-
graphical alterations to the pVSD environment n the R R in the immed at vi inity f the
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diamide binding site (Figure 8). Studying such changes provided useful information in
terms of identifying the extent/perimeters of the binding area [3,14]. However, within that
binding area, it is important to identify the residues responsible for forming intermolecular
forces (IMFs) with the diamide ligand.
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A recent study by Ma et al. [7] used a 3D homology model of P. xylostella RyR, based
on th high-resolution cryo-EM structure of rabbit rRyR1 in the open state in complex with
CLR, to identify key points of diamide interaction. This study determined that the CLR
molecule when bound induces a conformational change resulting in a displacement of the
S4–S5 linker, thereby triggering channel opening. The binding site for CLR, predicted to
be located within the pVSD of RyR and facing the cytosol, was further corroborated by
mutagenesis data, which revealed how the diamide insecticides are selective to P. xylostella.
Whereas the pyridine and pyrazole moieties of CLR are responsible for stabilizing the
ligand in the pocket, the anthraniloyl moiety accounts for the species-specific binding. The
defined binding pocket on rRyR1 has oppositely charged amino acid residues on each end,
contributed by R4563 and D4815, respectively (equivalent to residues K4700 and D4942 in
P. xylostella), which account for the majority (approx. 80%) of the binding energy interaction
with diamide insecticides. The modelling data also revealed that several pests have devel-
oped re istance t diamide insecticides via two mechani ms, steric hindrance (involving
I4790M/K and G4946E/V) and loss of contact (involv g Y4701C/D a d Y4922F).
A key residue identified by Ma et al. in their study [7] as being i volved in d amide
binding on rRyR1 is the positively charged R4563, equivalent to residue K4700 n P. xylostella,
which was also highlighted in he present study as being key CLR binding determinant.
This insect-specific lysine at positio 4700 is most likely largely responsibl for the affinity
of CLR for P. xylost lla RyR being ~200-fold higher compared to ammalian RyR1 [15],
possibly because it is a less bulky residu that better accommodates CLR in the bindi g
pocket. The P. xylostella RyR model also shows that residues Y4701, I4790 and S4919
(further highlighted in our study), as opposed to the equivalent residues F4564, C4657 and
L4792 in rRyR1, facilitate increased contact with CLR and results in a more favourable
interaction of the RyR binding pocket with the insecticide. This would account for the
decreased sensitivity to CLR observed in our experiments when some of these residues
were individually substituted for the rRyR1 equivalents in the P. xylostella RyR. Three of
these residues, K4700, Y4701 and S4919, are completely conserved in all insect species,
whereas I4790 is conserved only in the Lepidoptera, the equivalent residue in other insects
being a methionine (M), and must therefore confer some degree of specificity. Interestingly,
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our experiments showed that the substitution Y4701F does not adversely affect binding
of FLB but actually enhances the channel’s sensitivity to this compound, suggesting that
although the overall binding mode of CLR and FLB are similar, subtle differences in how
they interact with the binding pocket clearly exist.
The results presented highlight the toxicological relevance of a selection of amino
acid residues around the diamide binding site on P. xylostella RyR and extend further the
data presented by Ma et al. [7]. At least four of the five residues selected for our study,
K4700, Y4701, I4790, S4919, are involved in insect-specific binding of CLR [7]. The fifth
residue of the RFCLM quintet, involving the substitution V4945M, although not tested
as an individual RyR substitution in our study, is deemed unlikely to be substantially
involved in CLR binding, as it is located at the periphery of the binding pocket and faces
away from the binding site, as defined in the 3D RyR model.
4. Materials and Methods
4.1. Chemicals
Chemicals used for the preparation of bacterial media were purchased from Sigma
(Sigma-Aldrich, St. Louis, MO, USA). Analytical grade dimethyl sulfoxide (DMSO,
purity ≥ 99%) used for dilution of all active compounds was obtained from Sigma. Techni-
cal grade flubendiamide sulfoxide and chlorantraniliprole (purity > 98%) was provided
in-house (Bayer CropScience, Monheim am Rhein, Germany) or purchased as analyti-
cal standard from Fluka Chemicals (Buchs, Switzerland), respectively. Analytical grade
caffeine was purchased from ReagentPlus®(Sigma).
4.2. Mutagenesis of PxRyR
Construction of the pIZ-WT-PxRyR/V5-His plasmid used in this study is as described
in Troczka et al. [8]. The novel PxRyR modifications introduced during this study are listed
in Supplementary Table S1, along with the oligonucleotide sequences used to introduce the
change. Prior to mutagenesis, the 1,8177 bp pIZ-WT-PxRyR/V5-His construct was digested
into five fragments (detailed in Supplementary Figure S1) and each fragment was separately
incorporated into a pcDNA3.1(-) vector. All the listed changes in Supplementary Table S1
are to the C-fragment. A modification was made to the protocol previously described in [8]
to facilitate ease of fragment re-assembly (details available in Supplementary Methods M1).
Transformed, purified PxRyR assemblies were validated for completeness via diagnostic
digestion, complete amplification and complete Sanger sequencing (Eurofins Genomics,
Wolverhampton, UK). The RFCLM-PxRyR modification (containing the five alterations:
K4700R; Y4701F; I4790C; S4919L; V4945M) was generated using a Quick-Change Lightning
Multi kit (Agilent, Santa Clara, CA, USA), which allows the introduction of up to five
mutations simultaneously into an <8 kb plasmid. The protocol for the Lightning Multi kit
differs from the standard protocol above only in primer design, whereby two or more (up
to five) primers are used, with each primer capable of introducing one or more changes.
Uniquely, all the primers bind to one cDNA strand, with no complementary primer
binding required; instead, the Pfu enzyme extends the sequence from each primer, in non-
overlapping fashion, before knitting together the fragments to generate a single-stranded
DNA plasmid for transformation.
4.3. Sf9 Transfection Protocol
Spodoptera frugiperda Sf9 cells (Life Technologies, Carlsbad, CA, USA) were grown at
27 ◦C in Sf900TM II serum-free medium (SFM) (Gibco-Thermo Fisher Scientific, Waltham,
MA, USA) in 30 mL suspension cultures supplemented with 0.6% FBS (Gibco-Thermo
Fisher Scientific). Transfection of cells with the pIZ-PxRyR/V5-His expression plasmid and
CellfectinTM (Thermo Fisher Scientific) was performed according to the manufacturer’s
(Thermo Fisher Scientific) instructions. Glass coverslips (1 cm2 diameter) coated with
Poly-L-lysine (Sigma, Burlington, MA, USA) were placed in a 4-well plate. Each well
was then filled with 0.5 mL of Sf-900TM II medium and each coverslip was seeded with
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150,000 cells, at a density of 800 cells/mm2 to produce an approximately 90% confluent
monolayer. Cells were allowed to attach to the coverslips for 16 h and then were transfected.
Transfection solution was composed of 3.25 µg pIZ-PxRyR/V5-His plasmid DNA dissolved
in water; 4.5 µL PLUSTM enhancer reagent (Thermo Fisher Scientific); 20 µL CellfectinTM
(Thermo Fisher Scientific); per 1 mL of fresh Sf900TM II SFM. The Cellfectin and DNA:PLUS
solutions were individually mixed and incubated for 5 min, before being combined and
incubated for a further 30 min. Cells were removed from their media and washed twice,
prior to the addition of transfection solution. Transfection incubations proceeded for 4 h
before the cells were washed and returned to 30% conditioned SF900TM II SFM, with 0.6%
FBS. Post-transfection, cells were incubated at 27 ◦C for 40–52 h.
4.4. Calcium Imaging and Data Collection
Fura 2-AM dye (Life Technologies, Carlsbad, CA, USA) was used for monitoring
calcium release in Sf9 cells transfected with recombinant PxRyR. Cells were loaded with
Fura 2-AM calcium sensitive dye 48 h post transfection. Cells on coverslips in 4-well plates
were first put into 500 µL of fresh SF-900TM II SFM and then 2 µL of the dye stock solution
(1 mM) was added (to generate a final concentration of 4 µM). Cells were left to incubate at
27 ◦C for 45–60 min, followed by 3 washes with 500 µL of fresh unsupplemented SF-900TM
II SFM. Prior to imaging, coverslips with Fura-2-AM loaded cells were placed in standard
Ringer’s solution, with 2 mM [Ca2+] (CaCl2). All experiments were carried out in an air-
conditioned room maintained at approximately 25 ◦C. Data collection for all the calcium
imaging studies took place on a Ratiometric Imaging Perfusion system (RIPS), utilizing
an Axio Vert.A1 microscope with a LD Plan-Neofluar ×10/0.4 lens (Zeiss, Oberkochen,
Germany), measuring the ratio of excitation at 340/380 nm (calcium free/calcium bound
indicator) every 180 ms and capturing emission at 510 nm. Cells on the coverslip were
placed into a perfusion chamber of approximately 0.5 mL volume mounted on the micro-
scope stage. Continuous unidirectional flow of Ringer’s through the bath was driven by a
peristaltic pump, allowing for a constant fluid exchange. Caffeine and diamide agonist test
solutions were applied in 3 s bursts using a metal U-tube. Fluid dynamics were measured
using a solution of red amaranth dye, diluted 1:20 in Ringer’s. Perfusion flow rate was
49 µL/s. Experiments on cells consisted of multiple agonist applications, with the order
and timing of applications dependent on the experimental aims. Recordings began at
T = 0 s, with application of 10 mM caffeine at 7–10 s, followed by a 140 s delay, during
which period caffeine-responsive cells in the field-of-view (FOV) were identified (i.e., those
cells exhibiting a large biphasic Ca2+ event following the application of caffeine). During
concentration–response experiments a single caffeine application was followed by a single
diamide application at 150 s. Measurements were taken for all four PxRyR constructs in a
single day in order to minimise methodological variation, with between 6–25 cells respond-
ing for each construct. Experiments were recorded using VisiView®(Visitron Systems,
Puchheim, Germany) software. Raw video capture on the software was used to identify
caffeine-responsive cells and assess response mode. Outputted numerical pixel intensity
data were analysed using Microsoft Excel and SigmaPlot v.12 (Systat Software, Chicago,
IL, USA).
4.5. Agonist Diluent and Background Fluorescence
Due to their low solubility in water, stock PxRyR agonists used in this study were
dissolved initially in DMSO and then further diluted into Ringer’s medium at a dilution
factor of 1:100. As the 1% DMSO was found to cause a gradual rise in baseline Ca2+ in
some Sf9 cells (both transfected and non-transfected), the fluorescence amplitude of cells
exhibiting no change in fluorescence in response to caffeine was measured during each
diamide measurement and then subtracted from the fluorescence of each responding cell
in order to adjust for any DMSO-mediated fluorescence. Similarly, changes in background
fluorescence due to application of agonist frequently occur in non-ratiometric calcium
imaging, either due to changes in solution viscosity or due to poor dispersal of agonist
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in the media. In this present case, use of a ratiometric dye compensated for the issue of
background disturbance, and the effects occur equally at both ratiometric wavelengths
and therefore cancel each other out. Additionally, pluronic F68 (Gibco-Thermo Fischer
Scientific) was added to the final solutions of all agonists (including caffeine) at 0.003%
concentration, in order to aid the solubility of the diamide compounds [16].
4.6. Calculating Proportional Normalised Response (PNR) of Individual Cells to Diamide Insecticides
Responses of individual cells to the application of caffeine and then diamide com-
pounds were recorded. Diamide response amplitude was normalised to the prior caffeine
response to create a response ratio, which was then normalised against the maximal caffeine
responses to establish the proportional normalised response (PNR). In brief, to calculate the
PNR, raw data was normalized using the equation: R/R0, where R is the fluorescence ratio
value recorded for an individual cell upon each individual time point and R0 is an average
fluorescence ratio calculated over the first 5 s prior to addition of the agonist. The maximum
response amplitude is taken as the maximum fluorescence signal outputted by the cell
across all time frames. Final amplitude data is presented as a mean value and the standard
deviation of the mean. In all the concentration–response plots, response data is expressed
as a percentage of the highest response registered. The magnitude of Ca2+ release occurring
in response to diamide addition was normalized to the initial caffeine-evoked Ca2+ release
in the same cell (10 mM caffeine application occurs 150 s before diamide application). A
full description of the data analysis pipeline employed is provided in Appendix A.
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Appendix A
A data analysis pipeline consisting of the following steps was used to calculate the
PNR to diamide insecticides for each responding cell.
• Identify caffeine-responsive cells;
For each cell, the caffeine response was measured as follows:
n Calculate ‘average fluorescence prior to application’: R0
n Calculate ‘normalised fluorescence score at each timepoint’ for responding cells:
R/R0 response
n Calculate and subtract ‘cellular background’: (R/R0) total = (R/R0) response − (R/R0)non-response
n Calculate ‘maximum fluorescence amplitude’: ∆(R/R0) (Caffeine) = Max(R/R0)total − 1.
Similarly, measure response to diamide as follows:
n Calculate R0;
n Calculate R/R0;
n Calculate ∆R/R0 (Diamide);
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n For each cell, divide ∆R/R0 (Diamide/Caffeine) to get the PNR triggered by diamide.
The above was repeated for all cells in the FOV for the given dose, and the mean
average PNR across all cells in the FOV was calculated.
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